Thieme E-Books & E-Journals - Zeitschrift für Gastroenterologie / Issue

Goeppert, B; Frauenschuh, L; Zucknick, M; Roessler, S; Stenzinger, A; Warth, A; End, C; Mollenhauer, J; Vogel, M; Mehrabi, A; Hafezi, M; Schirmacher, P; Weichert, W; Renner, M:

Deleted in Malignant Brain Tumors 1 (DMBT1) is differentially expressed in cholangiocarcinogenesis and shows influence on patient survival

HTML

P_4_06

Ostroumov, D; Manns, MP; Kubicka, S; Kühnel, F; Wirth, T:

Development of an orthotopic HCC mouse model for analysis of tumor-specific CD8 T cell responses

HTML

P_4_07

Calvisi, DF; Frau, M; Feo, F; Pascale, RM; Dombrowski, F; Evert, M:

Die Aktivierung der DNA-dependent protein kinase catalytic subunit führt zur Hepatokarzinogenese und ist ein Prognosefaktor des Hepatozellulären Karzinoms

HTML

P_4_08

Vucur, M; Reisinger, F; Gautheron, J; Vargas Cardenas, D; Roderburg, C; Tacke, F; Trautwein, C; Heikenwälder, M; Luedde, T:

Die RIP3-abhängige Nekroptose inhibiert die inflammatorische Hepatokarzinogenese durch eine Hemmung der Caspase-8- und JNK-abhängigen kompensatorischen Zellproliferation

HTML

P_4_09

Yurttas, C; Berchtold, S; Malek, NP; Bitzer, MP; Lauer, UM:

Different 5-FC prodrug application regimes result in different oncolytic efficiencies

HTML

P_4_10

Wietzke-Braun, P; Guenther, R; Köpke, A; Bielefeld, T; Braun, F:

Differentialdiagnose des hiliären Cholangiocarcinoms (Klatskin-Tumor): Extrapankreatische Form einer IgG4-positiven Autoimmunpankreatitis – Ein Fallbericht

HTML

P_4_11

Venturelli, S; Berger, A; Weiland, T; Essmann, F; Waibel, M; Nübling, T; Häcker, S; Schulze-Osthoff, K; Salih, HR; Fulda, S; Sipos, B; Johnstone, RW; Lauer, UM; Bitzer, M:

Differentielle Induktion von Apotose und Therapie-induzierter Seneszenz (TIS) durch die beiden DNA-Methyltransferase Inhibitoren 5-Azacytidin und 5-Aza-2'-deoxycytidin

HTML

P_4_12

Buschauer, S; Hellerbrand, C:

Doxorubicin induces tumorigenicity and chemotherapy resistance of residual hepatocellular carcinoma cells in vitro

HTML

P_4_13

Lock, JF; Kotobi, AN; Stockmann, M:

Early lactate clearance as predictor of initial poor graft function after liver transplantation – a confirmative study

HTML

P_4_14

Marquardt, JU; Gomez-Quirez, L; Arreguin Camacho, LO; Pinna, F; Yun-Han, L; Kitade, M; Andersen, JB; Breuhahn, K; Galle, PR; Factor, VM; Thorgeirsson, SS:

Effective depletion of hepatic cancer stem-like cells by NF-kB mediated inhibiton of histone deacetylases

HTML

P_4_15

Jara, M; Bednarsch, J; Lock, JF; Neuhaus, P; Stockmann, M:

Einfluss Oxaliplatin-haltiger Chemotherapie auf die Leberfunktion – Ein Fallbericht

HTML

P_4_16

Hatting, M; Spannbauer, M; Cubero, FJ; Sellge, G; Gassler, N; Liedtke, C; Trautwein, C:

Fehlen von gp130 in Hepatozyten verringert die Tumorlast in einem Modell der chemisch induzierten Leberkarzinogenese

HTML

P_4_17

Liese, J; Peveling-Oberhag, J; Moench, C; Schnitzbauer, A; Welker, MW; Bechstein, WO; Ulrich, F:

Gibt es prädiktive Parameter für das frühe HCC-Rezidiv nach Lebertransplantation?

HTML

P_4_18

Koch, A; Wild, P; Bosserhoff, A; Hellerbrand, C:

Glucose transporter isoform 1 (GLUT1) expression determines tumorigenicity of melanoma cells and their potential to form hepatic metastasis

HTML

P_4_19

Cubero, FJ; Zhao, G; Nevzorova, YA; Al Masaoudi, M; Verdier, J; Peng, J; Schaefer, F; Hatting, M; Hermanns, N; Boekschoten, MV; Grouls, C; Gassler, N; Kiessling, F; Muller, M; Liedtke, C; Trautwein, C:

Hematopoietic cells-derived Jnk1 drives hepatic injury and hepatocellular carcinoma in IKKγ/NEMO-deleted livers

HTML

P_4_20

Koch, A; Dorn, C; Müller, M; Bosserhoff, A; Hellerbrand, C:

Hepatic steatosis enhances growth and invasiveness of hepatocellular carcinoma

HTML

P_4_21

Brückner, S; Tautenhahn, M; Winkler, S; Stock, P; Dollinger, M; Christ, B:

Hepatocytic Differentiated Mesenchymal Stem Cells for Translational Research in the Pig

HTML

P_4_22

Winkler, S; Brückner, S; Stock, P; Hempel, M; Christ, B:

Hepatogenic differentiated murine mesenchymal stem cells display functional qualities of perivenous and/or periportal hepatocytes

HTML

P_4_23

Loscher, C; Barikbin, R; Schildgen, J; Wulf, JH; Tiegs, G; Sass, G:

Identification of HO-1/CO-induced tumor protective genes in HCC

HTML

P_4_24

Heinzmann, F; Kang, TW; Hohmeyer, A; Schirmacher, P; Geffers, R; Longerich, T; Zender, L:

In vivo RNAi screen for new tumor suppressor genes in Hepatocellular Carcinoma

HTML

P_4_25

Lühr, CS; Quaas, A; Fahl, M; Lohse, AW; Schrader, J:

Induktion eines alternativen Makrophagenphänotyps durch die Tumorzellen im HCC

HTML

P_4_26

Lupke, M; Eggenhofer, E; Geissler, EK; Schlitt, HJ; Melter, M; Weiss, T:

Ischämie-Reperfusions vermittelter Schaden wird durch das Leberregenerations assoziiertes Protein ALR vermittelt

HTML

P_4_27

Ribback, S; Sonke, J; Hensel, A; Dombrowski, F:

Klarzellige Herde veränderter Hepatozyten nach intraportaler Pankreasinseltransplantation – Übertragung des Rattenmodells auf die Maus

HTML

P_4_28

Bühler, NEM; Thiel, K; Thiel, C; Schulze-Osthoff, K; Königsrainer, A; Schenk, M:

Kontrollierter Prozess zur Generierung einer azellularisierten Lebermatrix

HTML

P_4_29

Scheller, T; Hellerbrand, C; Schmidt, K; Geissler, EK; Schlitt, HJ; Lang, SA:

mTOR Inhibition verbessert die Effektivität der FGFR Blockade im HCC Modell

HTML

P_4_30

Waldburger, N; Habbe, N; Schulze, F; Lindenmaier, H; Ulrich, F; Bechstein, WO; Schirmacher, P; Longerich, T:

Multifocal β-catenin activated hepatocellular adenomas (HCA) with malignant transformation in hepatocellular carcinoma (HCC) after abuse of anabolic steroids

HTML

P_4_31

Rudalska, R; Dauch, D; McJunkin, K; Kang, TW; Wuestefeld, T; Geffers, R; Schirmacher, P; Lowe, S; Longerich, T; Laufer, S; Zender, L:

Multiplex in vivo RNAi screening instructs combination therapies to increase the therapeutic efficacy of the multikinase inhibitor sorafenib

HTML

P_4_32

Guenther, R; Wietzke-Braun, P; Bielefeldt, T; Kataev, V; Braun, F:

Nebenwirkungsspektrum während und nach erfolgreicher HCV Triple-Therapie nach Leberlebendtransplantation

HTML

P_4_33

Pesic, M; Wolter, K; Wuestefeld, T; Kang, TW; Chawla, R; Geffers, R; Klawonn, F; Schirmacher, P; Malek, N; Premsrirut, PK; Longerich, T; Zender, L:

Negative Selection In Vivo RNAi Screening Identifies a Ribosomal Protein As A New Therapeutic Target In Liver Cancer

HTML

P_4_34

Bozko, P; El Khatib, M; Palagani, V; Malek, N; Wilkens, L; Plentz, R:

Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo

HTML

P_4_35

Mahli, A; Thasler, WE; Müller, M; Hellerbrand, C:

Novel in vitro model for combined effects of irinotecan and free fatty acids on hepatocellular lipid accumulation and inflammation

HTML

P_4_36

Struecker, B; Butter, A; Hillebrandt, K; Selke, A; Raschzok, N; Sauer, I:

Optimierung der Rattenleber-Dezellularisierung durch arterielle Perfusion unter oszillierenden Umgebungsdruckschwankungen

HTML

P_4_37

Wang, J; Deng, X; Pathil, A; Stremmel, W; Chamulitrat, W:

Protective role of Ursodeoxycholyl Lysophosphatidylethanolamide during hepatic ischemia and reperfusion injury in mice

HTML

P_4_38

Gürlevik, E; Fleischmann-Mundt, B; Brooks, J; Woller, N; Manns, MP; Kubicka, S; Kühnel, F:

Resectable transgenic tumor models in mice for biliary cancers

HTML

P_4_39

Kloos, A; Gürlevik, E; Woller, N; Ureche, CI; Manns, MP; Gerardy-Schahn, R; Kubicka, S; Kühnel, F:

Retargeting of oncolytic adenoviruses by bispecific adapter molecules reduces viral liver load and improves therapy by triggering antigen-specific CD8 T-cell responses

HTML

P_4_40

Pinna, F; Bissinger, M; Schirmacher, P; Breuhahn, K:

Role of A20(TNFAIP3) in mediating TNFα-induced pathways activation in mouse hepatoma cell lines and primary hepatocytes

HTML

P_4_41

Dediulia, T; Dropmann, A; Itzel, T; Meindl-Beinker, N; Teufel, A; Cai, S; ten Dijke, P; Dooley, S:

Screening for TGFB Signaling Regulator expression in human HCC

HTML

P_4_42

Berchtold, S; Weiland, T; Lampe, J; Smirnow, I; Venturelli, S; Berger, A; Reiser, J; Stubenrauch, F; Malek, NP; Bitzer, M; Lauer, UM:

Secondary resistances to measles virus (MeV)-based virotherapy

HTML

P_4_43

Finkelmeier, F; Köberle, V; Bojunga, J; Kronenberger, B; Zeuzem, S; Trojan, J; Piiper, A; Waidmann, O:

Severe 25-hydroxyvitamin D deficiency identifies HCC patients with a poor prognosis

HTML

P_4_44

Finkelmeier, F; Bettinger, D; Köberle, V; Schultheiß, M; Kronenberger, B; Piiper, A; Waidmann, O:

Single measurement of hemoglobin predicts outcome of HCC patients

HTML

P_4_45

Samarin, J; Stein, I; Horwitz, E; Ho, C; Chen, X; Pikarsky, E; Calvisi, D; Schirmacher, P; Breuhahn, K:

Stabilization of protumorigenic FUSE binding proteins (FBPs) in hepatocarcinogenesis

HTML

P_4_46

Weinmann, A; Koch, S; Schulze-Bergkamen, H; Sprinzl, M; Düber, C; Lang, H; Otto, G; Woerns, MA; Galle, PR:

Survival analysis of proposed BCLC B subgroups in hepatocellular carcinoma patients

HTML

P_4_47

Calvisi, DF; Tao, J; Ranganathan, S; Cigliano, A; Jiang, L; Fan, B; Armeanu-Ebinger, S; Delogu, S; Ribback, S; Dombrowski, F; Monga, SPS; Chen, X; Evert, M: